Direct Relief and ViiV Healthcare Deliver Pediatric Dolutegravir to Rwanda to Combat HIV Treatment Gaps and Drug Resistance
Direct Relief and ViiV Healthcare are delivering pediatric-formulated dolutegravir—a second-line antiretroviral—to Rwanda to close a critical treatment gap for children under 12 with HIV. The initiative targets drug-resistant strains caused ... Read More